MedTrace Logo

Randomized Comparison of PARtial Wrist Fusion With or Without Triquetral Excision (PARTE)

NCT04580225 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2025-11-18

No results posted yet for this study

Summary

This randomized clinical trial (RCT) aims to compare clinical and radiographic outcomes of different partial wrist fusion techniques in participants with post-traumatic wrist arthritis. Participants with stage II or III scapholunate advanced collapse (SLAC) or scaphoid nonunion advanced collapse (SNAC) who meet the eligibility criteria will be randomly assigned to one of two parallel groups: Group A (partial wrist arthrodesis without triquetral excision i.e. four-corner arthrodesis), or Group B (partial wrist arthrodesis with triquetral excision i.e. three-corner or capitolunate arthrodesis with triquetral excision). The results of this study will provide evidence to guide surgeons in determining the ideal wrist fusion technique in the management of patients with post-traumatic wrist arthritis requiring surgery.

Conditions

  • Wrist Arthritis
  • Wrist Arthropathy
  • Scapholunate Advanced Collapse
  • Scaphoid Nonunion
  • Post-traumatic; Arthrosis
  • Arthritis
  • Musculoskeletal Diseases
  • Joint Diseases

Interventions

PROCEDURE

Four-Corner Arthrodesis

Participants in Group A will receive a four-corner arthrodesis (fusion of the capitate, hamate, lunate, and triquetrum) with excision of the scaphoid.

PROCEDURE

Three-Corner or Capitolunate Arthrodesis with Triquetral Excision

Participants in Group B will receive a three-corner arthrodesis (fusion of the capitate, hamate, and lunate) or capitolunate arthrodesis (fusion of the capitate and lunate) with excision of the scaphoid and triquetrum.

Sponsors & Collaborators

  • Arthritis Society Canada

    collaborator UNKNOWN

  • Wrist Evaluation Canada (WECAN)

    collaborator UNKNOWN

  • University of Alberta

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-07
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04580225 on ClinicalTrials.gov